Work

Predicting CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

Year: 2015

Type: conference-abstract

Abstract: Meeting abstracts Monoclonal antibody (mAb) therapy-has changed the natural history of patients with B cell lymphomas, breast cancer, and head and neck cancers. However, response rates are suboptimal, highlighting the need to enhance mAb activity. Combining a tumor targeting mAb with a second

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p98

Authors: Amani Makkouk, Vandana Sundaram, Manisha Desai, Cariad Chester, Holden Maecker, Holbrook E Kohrt

Institution: Stanford University

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490